These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites. Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748 [TBL] [Abstract][Full Text] [Related]
4. [Effect of ethyl alcohol on bile production and lipid peroxidation in tetracycline-induced liver lesions]. Skakun NP; Oleĭnik AN; Shman'ko VV; Koval'chuk NA; Koval'chuk SF Antibiot Med Biotekhnol; 1985 Feb; 30(2):115-8. PubMed ID: 4039911 [TBL] [Abstract][Full Text] [Related]
6. [Lipid peroxidation and bile formation in a paracetamol lesion of the liver]. Skakun NP; Shman'ko VV Farmakol Toksikol; 1984; 47(4):105-8. PubMed ID: 6479308 [TBL] [Abstract][Full Text] [Related]
7. Hepatic drug metabolism and adverse hepatic drug reactions. Schaffner F Vet Pathol; 1975; 12(2):145-56. PubMed ID: 171822 [TBL] [Abstract][Full Text] [Related]
9. Protective agents for acetaminophen overdose. Davis M Semin Liver Dis; 1986 May; 6(2):138-47. PubMed ID: 3529407 [No Abstract] [Full Text] [Related]
10. [Drug- and toxin-induced hepatotoxicity]. Grünhage F; Fischer HP; Sauerbruch T; Reichel C Z Gastroenterol; 2003 Jun; 41(6):565-78. PubMed ID: 12806543 [TBL] [Abstract][Full Text] [Related]
11. Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism. Farrell GC; Cooksley WG; Hart P; Powell LW Gastroenterology; 1978 Oct; 75(4):580-8. PubMed ID: 710827 [TBL] [Abstract][Full Text] [Related]
12. [Recent findings on the hepatotoxicity of drugs]. Altomare E; Vendemiale G; Stufano N; Di Monte D; Procacci V; Albano O Recenti Prog Med; 1985 Nov; 76(11):598-605. PubMed ID: 3912875 [No Abstract] [Full Text] [Related]
13. Reactive metabolites as a cause of hepatotoxicity. Prescott LF Int J Clin Pharmacol Res; 1983; 3(6):437-41. PubMed ID: 6381340 [TBL] [Abstract][Full Text] [Related]
14. Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets. Paumgartner G World J Gastroenterol; 2006 Jul; 12(28):4445-51. PubMed ID: 16874853 [TBL] [Abstract][Full Text] [Related]
16. [Drug-induced liver lesions]. Teschke R Dtsch Med Wochenschr; 1983 Feb; 108(5):190-4. PubMed ID: 6402354 [No Abstract] [Full Text] [Related]
17. Drug metabolism in the production of liver injury. Mitchell JR; Potter WZ Med Clin North Am; 1975 Jul; 59(4):877-85. PubMed ID: 238084 [No Abstract] [Full Text] [Related]
18. Drug hepatotoxicity. Timbrell JA Br J Clin Pharmacol; 1983 Jan; 15(1):3-14. PubMed ID: 6342638 [No Abstract] [Full Text] [Related]
19. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation. Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940 [TBL] [Abstract][Full Text] [Related]
20. Involvement of cytochrome P450-mediated metabolism in tienilic acid hepatotoxicity in rats. Nishiya T; Kato M; Suzuki T; Maru C; Kataoka H; Hattori C; Mori K; Jindo T; Tanaka Y; Manabe S Toxicol Lett; 2008 Dec; 183(1-3):81-9. PubMed ID: 18992796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]